🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate the efficacy of dupilumab in children 6 to ...
Status
Completed
Location
Investigational Site Number 840031
Start Date
2017-04-21
Trial ID
NCT02948959
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab, compared with pl...
Status
Completed
Location
Investigational Site Number 840022
Start Date
2015-10-15
Trial ID
NCT02528214
Primary Objective: To evaluate the efficacy of dupilumab (SAR231893 / REGN...
Status
Completed
Location
Investigational Site Number 840047
Start Date
2015-04-27
Trial ID
NCT02414854
The purpose of this study is to assess the efficacy and safety of short rag...
Status
Completed
Location
Multiple Locations
Start Date
2015-07-20
Trial ID
NCT02478398
This purpose of this study is to determine the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00562159
To investigate the Efficacy and Safety of Levalbuterol versus Racemic Albut...
Status
Completed
Location
Multiple Locations
Start Date
2000-11
Trial ID
NCT00667407
Treatments Being Tested
The purpose of the study is to investigate the efficacy and safety of a gra...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00550550
To investigate the efficacy and safety of repeated dosing of Levalbuterol o...
Status
Completed
Location
Multiple Locations
Start Date
2002-02
Trial ID
NCT00665600
Treatments Being Tested
A Safety, Efficacy, and Tolerability Study of Daily Dosing with Levalbutero...
Status
Completed
Location
Little Rock Allergy & Asthma Clinical Research Center
Start Date
2008-12
Trial ID
NCT00809757
Treatments Being Tested
To determine the safety and tolerability of Arformoterol Tartrate in childr...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00583947
Treatments Being Tested